Literature DB >> 24120180

Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory.

Melina Arnold1, Henrike E Karim-Kos2, Jan Willem Coebergh3, Graham Byrnes4, Ahti Antilla5, Jacques Ferlay6, Andrew G Renehan7, David Forman6, Isabelle Soerjomataram6.   

Abstract

BACKGROUND: Individual country- and cancer site-specific studies suggest that the age-adjusted incidence of many common cancers has increased in European populations over the past two decades. To quantify the extent of these trends and the recent burden of cancer, here we present a comprehensive overview of trends in population-based incidence of the five common cancers across Europe derived from a new web-based portal of the European cancer registries.
METHODS: Data on incidence for cancers of the colon and rectum, prostate, breast, corpus uteri and stomach diagnosed from 1988 to 2008 were obtained from the European Cancer Observatory for cancer registries from 26 countries. Annual age-standardised incidence rates and average annual percentage changes were calculated.
RESULTS: Incidence of four common cancers in eastern and central European countries (prostate, postmenopausal breast, corpus uteri and colorectum) started to approach levels in northern and western Europe, where rates were already high in the past but levelled off in some countries in recent years. Decreases in stomach cancer incidence were seen in all countries. DISCUSSION: Increasing trends in incidence of the most common cancers, except stomach cancer, are bad news to public health but can largely be explained by well-known changes in society in the past decades. Thus, current and future efforts in primary cancer prevention should not only remain focussed on the further reduction of smoking but engage in the long-term efforts to retain healthy lifestyles, especially avoiding excess weight through balanced diets and regular physical exercise.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer registry; Europe/epidemiology; Neoplasms; Public health surveillance; Trends

Mesh:

Year:  2013        PMID: 24120180     DOI: 10.1016/j.ejca.2013.09.002

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  122 in total

1.  Dose-volume Histogram-based Predictors for Hematuria and Rectal Hemorrhage in Patients Receiving Radiotherapy After Radical Prostatectomy.

Authors:  Katsuyuki Shirai; Masato Suzuki; Keiko Akahane; Yuta Takahashi; Masahiro Kawahara; Erika Yamada; Masaru Wakatsuki; Kazunari Ogawa; Satrou Takahashi; Kyosuke Minato; Kohei Hamamoto; Kimitoshi Saito; Masashi Oshima; Tsuzumi Konishi; Yuhki Nakamura; Satoshi Washino; Tomoaki Miyagawa
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age.

Authors:  Derya Tilki; Valentin Maurer; Raisa S Pompe; Felix K Chun; Felix Preisser; Alexander Haese; Markus Graefen; Hartwig Huland; Philipp Mandel
Journal:  World J Urol       Date:  2019-04-02       Impact factor: 4.226

3.  Surgical site infections after radical prostatectomy: A comparative study between robot-assisted laparoscopic radical prostatectomy and retropubic radical prostatectomy.

Authors:  Daniar K Osmonov; Amr A Faddan; Alexey V Aksenov; Carsten M Naumann; Leonid M Rapoport; Evgeny A Bezrukov; Dmitry G Tsarichenko; Klaus P Jünemann
Journal:  Turk J Urol       Date:  2018-07

Review 4.  The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer.

Authors:  Elizabeth Cartwright; David Cunningham
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

5.  Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates.

Authors:  Philipp Mandel; Su J Oh; Christoph Hagner; Pierre Tennstedt; Maximilian C Kriegmair; Hartwig Huland; Markus Graefen; Derya Tilki
Journal:  World J Urol       Date:  2016-03-22       Impact factor: 4.226

6.  Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.

Authors:  Jihyoun Jeon; Rafael Meza; William D Hazelton; Andrew G Renehan; E Georg Luebeck
Journal:  Cancer Causes Control       Date:  2015-03-18       Impact factor: 2.506

7.  Postmenopausal breast cancer: European challenge and innovative concepts.

Authors:  Ivica Smokovski; Milan Risteski; Jiri Polivka; Pavol Zubor; Katarzyna Konieczka; Vincenzo Costigliola; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-05-30       Impact factor: 6.543

Review 8.  [Radical prostatectomy in locally advanced prostate cancer].

Authors:  P Mandel; D Tilki; M Graefen
Journal:  Urologe A       Date:  2017-11       Impact factor: 0.639

9.  Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.

Authors:  R Clèries; R M Rooney; M Vilardell; J A Espinàs; T Dyba; J M Borras
Journal:  Clin Transl Oncol       Date:  2017-07-19       Impact factor: 3.405

10.  Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.

Authors:  Xianzhe Liu; Yan Gao; Jacson Shen; Wen Yang; Edwin Choy; Henry Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  Mol Cancer Ther       Date:  2016-05-20       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.